πŸ‡ΊπŸ‡Έ FDA

Intelligence Platform

Patents

Browse 3,720 pharma-relevant patents (US and EP, A61K/A61P) linked to tracked companies. Patent cliff and LOE intelligence for BD teams.

29,054 patents indexed
patent

US 6756399

Use of lipoxygenase inhibitors and PPAR ligands as anti-cancer therapeutic and interventio

The United States of America, as represented by the Department of Health and Human Services Β· Granted Tue Jun 29 2004 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jun 24 2024 00:00:00 GMT+0000 (Coordinated Universal Time)

expired
patent

US 6756201

Diagnostic methods and gene therapy using reagents derived from the human metastasis suppr

The United States of America as represented by the Department of Health and Services Β· Granted Tue Jun 29 2004 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jun 24 2024 00:00:00 GMT+0000 (Coordinated Universal Time)

expired
patent

US 6756038

Agonist and antagonist peptides of carcinoembryonic antigen (CEA)

The United States of America, as represented by the Department of Health and Human Services Β· Granted Tue Jun 29 2004 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jun 24 2024 00:00:00 GMT+0000 (Coordinated Universal Time)

expired
patent

US 6756033

Method for delivering benzindene prostaglandins by inhalation

United Therapeutics Corporation Β· Granted Tue Jun 29 2004 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jun 24 2024 00:00:00 GMT+0000 (Coordinated Universal Time)

expired
patent

US 6753317

Dmt-Tic di- and tri-peptide derivatives and related compositions and methods of use

The United States of America, as represented by the Department of Health and Human Services Β· Granted Tue Jun 22 2004 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jun 17 2024 00:00:00 GMT+0000 (Coordinated Universal Time)

expired
patent

US 6750254

Nitric oxide-releasing amidine—and enamine-derived diazeniumdiolates, compositions a

The United States of America, as represented by the Department of Health and Human Services Β· Granted Tue Jun 15 2004 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jun 10 2024 00:00:00 GMT+0000 (Coordinated Universal Time)

expired
patent

US 6749856

Mucosal cytotoxic T lymphocyte responses

The United States of America, as represented by the Department of Health and Human Services Β· Granted Tue Jun 15 2004 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jun 10 2024 00:00:00 GMT+0000 (Coordinated Universal Time)

expired
patent

US 6747055

Water-soluble drugs and methods for their production

The United States of America, as represented by the Department of Health and Human Services Β· Granted Tue Jun 08 2004 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jun 03 2024 00:00:00 GMT+0000 (Coordinated Universal Time)

expired
patent

US 6743797

Methods for treating cardiac arrhythmia

The United States of America Β· Granted Tue Jun 01 2004 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon May 27 2024 00:00:00 GMT+0000 (Coordinated Universal Time)

expired
patent

US 6743626

Artificial salivary gland

The United States of America, as represented by the Department of Health and Human Services Β· Granted Tue Jun 01 2004 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon May 27 2024 00:00:00 GMT+0000 (Coordinated Universal Time)

expired
patent

US 6743577

Methods of using cyanovirins to inhibit viral infection

The United States of America, as represented by the Department of Health and Human Services Β· Granted Tue Jun 01 2004 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon May 27 2024 00:00:00 GMT+0000 (Coordinated Universal Time)

expired
patent

US 6737511

Receptor-mediated uptake of an extracellular BCL-xL fusion protein inhibits apoptosis

The United States of America, as represented by the Department of Health and Human Services Β· Granted Tue May 18 2004 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon May 13 2024 00:00:00 GMT+0000 (Coordinated Universal Time)

expired
patent

US 6737251

Nucleotide and deduced amino acid sequences of tumor gene Int6

The United States of America, as represented by the Department of Health and Human Services Β· Granted Tue May 18 2004 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon May 13 2024 00:00:00 GMT+0000 (Coordinated Universal Time)

expired
patent

US 6734014

Methods and compositions for transforming dendritic cells and activating T cells

The United States of America, as represented by the Department of Health and Human Services Β· Granted Tue May 11 2004 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon May 06 2024 00:00:00 GMT+0000 (Coordinated Universal Time)

expired
patent

US 6730498

Production of functional proteins: balance of shear stress and gravity

The United States of America as represented by the Administrator of the National Aeronautics and Space Administration Β· Granted Tue May 04 2004 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Apr 29 2024 00:00:00 GMT+0000 (Coordinated Universal Time)

expired
patent

US 6719978

Virus-like particles for the induction of autoantibodies

The United States of America, as represented by the Department of Health and Human Services Β· Granted Tue Apr 13 2004 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Apr 08 2024 00:00:00 GMT+0000 (Coordinated Universal Time)

expired
patent

US 6716450

Enhancing protein activity through nanoencapsulation

The United States of America as represented by the Secretary of the Army Β· Granted Tue Apr 06 2004 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Apr 01 2024 00:00:00 GMT+0000 (Coordinated Universal Time)

expired
patent

US 6713444

Buforin I as a specific inhibitor and therapeutic agent for botulinum toxin B and tetanus

The United States of America as represented by the Secretary of the Army Β· Granted Tue Mar 30 2004 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Mar 25 2024 00:00:00 GMT+0000 (Coordinated Universal Time)

expired
patent

US 6713301

Artificial T helper cell epitopes as immune stimulators for synthetic peptide immunogens

United Biomedical, Inc. Β· Granted Tue Mar 30 2004 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Mar 25 2024 00:00:00 GMT+0000 (Coordinated Universal Time)

expired
patent

US 6713284

Bacterial superantigen vaccines

The United States of America as represented by the Secretary of the Army Β· Granted Tue Mar 30 2004 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Mar 25 2024 00:00:00 GMT+0000 (Coordinated Universal Time)

expired
patent

US 6713081

Ocular therapeutic agent delivery devices and methods for making and using such devices

The United States of America, as represented by the Department of Health and Human Services Β· Granted Tue Mar 30 2004 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Mar 25 2024 00:00:00 GMT+0000 (Coordinated Universal Time)

expired
patent

US 6713066

Production of attenuated respiratory syncytial virus vaccines involving modification of M2

The United States of America, as represented by the Department of Health and Human Services Β· Granted Tue Mar 30 2004 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Mar 25 2024 00:00:00 GMT+0000 (Coordinated Universal Time)

expired
patent

US 6713446

Formulation of boronic acid compounds

The United States of America as Represented by the Secretary of the Department of Health and Human Services Β· Granted Tue Mar 30 2004 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Mar 25 2024 00:00:00 GMT+0000 (Coordinated Universal Time)

expired
patent

US 6710166

41 kDa Cryptosporidium parvum oocyst wall protein

The United States of America, as represented by the Secretary of Agriculture Β· Granted Tue Mar 23 2004 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Mar 18 2024 00:00:00 GMT+0000 (Coordinated Universal Time)

expired